We found that MD2 inhibition with L6H21 (both prevention and treatment) was as effective as MD2 knockout in preventing the progression of inflammatory injury and fibrosis in the liver with NASH, which was associated with inhibition of the MD2‐TLR4 complex formation as well. Here, TLR4 is linked to metabolic dysfunction-associated steatohepatitis.